细胞辅助脂质转移治疗无法控制的脓毒症相关肛周瘘管:一项试点研究。

IF 3 Q2 GASTROENTEROLOGY & HEPATOLOGY
Annals of Coloproctology Pub Date : 2024-04-01 Epub Date: 2023-02-06 DOI:10.3393/ac.2022.00486.0069
In Seob Jeong, Sung Hwan Hwang, Hye Mi Yu, Hyeonseok Jeong
{"title":"细胞辅助脂质转移治疗无法控制的脓毒症相关肛周瘘管:一项试点研究。","authors":"In Seob Jeong, Sung Hwan Hwang, Hye Mi Yu, Hyeonseok Jeong","doi":"10.3393/ac.2022.00486.0069","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Surgeons can treat debilitating conditions of uncontrollable complex anorectal fistulas with sepsis, even after repeated fistula surgeries, for curative intention. Adipose-derived stem cells have shown good outcomes for refractory Crohn fistula. Unfortunately, cell therapy has some limitations, including high costs. We have therefore attempted immediate cell-assisted lipotransfer (CAL) in treating refractory complex anal fistulas and observed its outcomes.</p><p><strong>Methods: </strong>In a retrospective study, CAL, using a mixture of freshly extracted autologous stromal vascular fraction (SVF) and fat tissues, was used to treat 22 patients of refractory complex anal fistula from March 2018 to May 2021. Preoperative and postoperative assessments were performed with direct visual inspection, digital palpation, and endoanal ultrasonography. A fistula was considered completely healed if (1) the patient had no symptoms of discharge or inflammation; (2) there were no visible secondary openings of fistula tract inside and outside of the anorectal unit and even in the perineum; and (3) there was no primary opening in the anus. The endpoint of complete remission was wound healing without signs of inflammation 3 months after CAL treatment.</p><p><strong>Results: </strong>In a total of 22 patients who received CAL treatment, 19 patients showed complete remission, 1 patient showed partial improvement, and 2 patients showed no improvement. One of the 2 patients without improvement at primary endpoint showed complete remission 9 months after CAL. There were no significant adverse effects of the procedure.</p><p><strong>Conclusion: </strong>We found that the immediately-collected CAL procedure for refractory complex anal fistula showed good outcomes without adverse side effects. It can be strongly recommended as an alternative surgical option for the treatment of complex anal fistula that is uncontrollable even after repeated surgical procedures. However, considering the unpredictable characteristics of SVF, long-term follow-up is necessary.</p>","PeriodicalId":8267,"journal":{"name":"Annals of Coloproctology","volume":" ","pages":"169-175"},"PeriodicalIF":3.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082549/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cell-assisted lipotransfer in treating uncontrollable sepsis associated perianal fistula: a pilot study.\",\"authors\":\"In Seob Jeong, Sung Hwan Hwang, Hye Mi Yu, Hyeonseok Jeong\",\"doi\":\"10.3393/ac.2022.00486.0069\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Surgeons can treat debilitating conditions of uncontrollable complex anorectal fistulas with sepsis, even after repeated fistula surgeries, for curative intention. Adipose-derived stem cells have shown good outcomes for refractory Crohn fistula. Unfortunately, cell therapy has some limitations, including high costs. We have therefore attempted immediate cell-assisted lipotransfer (CAL) in treating refractory complex anal fistulas and observed its outcomes.</p><p><strong>Methods: </strong>In a retrospective study, CAL, using a mixture of freshly extracted autologous stromal vascular fraction (SVF) and fat tissues, was used to treat 22 patients of refractory complex anal fistula from March 2018 to May 2021. Preoperative and postoperative assessments were performed with direct visual inspection, digital palpation, and endoanal ultrasonography. A fistula was considered completely healed if (1) the patient had no symptoms of discharge or inflammation; (2) there were no visible secondary openings of fistula tract inside and outside of the anorectal unit and even in the perineum; and (3) there was no primary opening in the anus. The endpoint of complete remission was wound healing without signs of inflammation 3 months after CAL treatment.</p><p><strong>Results: </strong>In a total of 22 patients who received CAL treatment, 19 patients showed complete remission, 1 patient showed partial improvement, and 2 patients showed no improvement. One of the 2 patients without improvement at primary endpoint showed complete remission 9 months after CAL. There were no significant adverse effects of the procedure.</p><p><strong>Conclusion: </strong>We found that the immediately-collected CAL procedure for refractory complex anal fistula showed good outcomes without adverse side effects. It can be strongly recommended as an alternative surgical option for the treatment of complex anal fistula that is uncontrollable even after repeated surgical procedures. However, considering the unpredictable characteristics of SVF, long-term follow-up is necessary.</p>\",\"PeriodicalId\":8267,\"journal\":{\"name\":\"Annals of Coloproctology\",\"volume\":\" \",\"pages\":\"169-175\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082549/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Coloproctology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3393/ac.2022.00486.0069\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/2/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Coloproctology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3393/ac.2022.00486.0069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:外科医生可以治疗无法控制的复杂性肛瘘并伴有败血症,甚至在反复进行肛瘘手术后仍能达到治愈目的。脂肪源性干细胞对难治性克罗恩瘘有良好疗效。遗憾的是,细胞疗法存在一些局限性,包括成本高昂。因此,我们尝试用细胞辅助脂肪移植(CAL)治疗难治性复杂性肛瘘,并观察其疗效:在一项回顾性研究中,从2018年3月至2021年5月,我们使用新鲜提取的自体基质血管成分(SVF)和脂肪组织的混合物进行CAL,治疗了22例难治性复杂肛瘘患者。术前和术后评估通过直接目测、数字触诊和肛内超声检查进行。如果(1)患者没有分泌物或炎症症状;(2)肛门直肠内外甚至会阴部没有可见的瘘道继发开口;(3)肛门没有原发开口,则认为肛瘘完全愈合。完全缓解的终点是 CAL 治疗 3 个月后伤口愈合且无炎症迹象:结果:在接受 CAL 治疗的 22 名患者中,19 名患者病情完全缓解,1 名患者病情部分好转,2 名患者病情没有好转。在主要终点未见好转的 2 名患者中,有一人在 CAL 治疗 9 个月后病情完全缓解。手术无明显不良反应:我们发现,立即采集的 CAL 术治疗难治性复杂性肛瘘效果良好,且无不良副作用。结论:我们发现,立即采集 CAL 术治疗难治性复杂肛瘘效果良好,且无不良副作用,可作为治疗复杂肛瘘的替代手术方案予以大力推广。不过,考虑到 SVF 难以预测的特点,有必要进行长期随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cell-assisted lipotransfer in treating uncontrollable sepsis associated perianal fistula: a pilot study.

Purpose: Surgeons can treat debilitating conditions of uncontrollable complex anorectal fistulas with sepsis, even after repeated fistula surgeries, for curative intention. Adipose-derived stem cells have shown good outcomes for refractory Crohn fistula. Unfortunately, cell therapy has some limitations, including high costs. We have therefore attempted immediate cell-assisted lipotransfer (CAL) in treating refractory complex anal fistulas and observed its outcomes.

Methods: In a retrospective study, CAL, using a mixture of freshly extracted autologous stromal vascular fraction (SVF) and fat tissues, was used to treat 22 patients of refractory complex anal fistula from March 2018 to May 2021. Preoperative and postoperative assessments were performed with direct visual inspection, digital palpation, and endoanal ultrasonography. A fistula was considered completely healed if (1) the patient had no symptoms of discharge or inflammation; (2) there were no visible secondary openings of fistula tract inside and outside of the anorectal unit and even in the perineum; and (3) there was no primary opening in the anus. The endpoint of complete remission was wound healing without signs of inflammation 3 months after CAL treatment.

Results: In a total of 22 patients who received CAL treatment, 19 patients showed complete remission, 1 patient showed partial improvement, and 2 patients showed no improvement. One of the 2 patients without improvement at primary endpoint showed complete remission 9 months after CAL. There were no significant adverse effects of the procedure.

Conclusion: We found that the immediately-collected CAL procedure for refractory complex anal fistula showed good outcomes without adverse side effects. It can be strongly recommended as an alternative surgical option for the treatment of complex anal fistula that is uncontrollable even after repeated surgical procedures. However, considering the unpredictable characteristics of SVF, long-term follow-up is necessary.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.30
自引率
3.20%
发文量
73
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信